MedTrace Logo

Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients

NCT03594448 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-08-29

No results posted yet for this study

Summary

This pilot trial studies how well serial liquid biopsies work in detecting microsatellite instability in participants with stage IV colorectal cancer. Serial liquid biopsies may help doctors learn better methods to track cancer in the bloodstream and how to use these to improve cancer treatments.

Conditions

  • Microsatellite Instability
  • Colorectal Cancer Stage IV

Interventions

PROCEDURE

Specimen Collection

Undergo collection of blood samples

PROCEDURE

Serial Liquid Biopsy

Undergo serial liquid biopsy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Heinz Josef Lenz, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-05
Primary Completion
2023-09-18
Completion
2023-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594448 on ClinicalTrials.gov